Developments in the pharmacological treatment of schizophrenia. (Q34974846)

From Wikidata

Revision as of 09:20, 29 March 2019 by Renamerr (talk | contribs) (‎Changed Ukrainian description: наукова стаття, опублікована в жовтні 2002, #quickstatements; batch #9788 by User:Renamerr)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Developments in the pharmacological treatment of schizophrenia.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Developments in the pharmacological treatment of schizophrenia. (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

0 references

object named as

Robin Murray

3

0 references

author name string

Gina Kuperberg

1

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Robert Kerwin

2

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

publication date

1 October 2002

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Expert Opinion on Investigational Drugs

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

1335-1341

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Compliance therapy in psychotic patients: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1335

21 January 2018

Treatment of negative symptoms

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1335

21 January 2018

Longitudinal assessment of premorbid cognitive functioning in patients with schizophrenia through examination of standardized scholastic test performance.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1335

21 January 2018

Generalized cognitive deficits in schizophrenia: a study of first-episode patients.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1335

21 January 2018

Dopamine receptor pharmacology

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1335

21 January 2018

Genetic polymorphisms of the dopamine D2 and D3 receptor and neuroleptic drug effects in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1335

21 January 2018

Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1335

21 January 2018

Failure to find linkage between a functional polymorphism in the dopamine D4 receptor gene and schizophrenia

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1335

21 January 2018

No difference in the expression of the D4 gene in post-mortem frontal cortex from controls and schizophrenics

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1335

21 January 2018

3-((4-(4-Chlorophenyl)piperazin-1-yl)-methyl)-1H-pyrrolo-2,3-b-pyridine: an antagonist with high affinity and selectivity for the human dopamine D4 receptor

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1335

21 January 2018

Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1335

21 January 2018

(-)-Stepholidine: a potential novel antipsychotic drug with dual D1 receptor agonist and D2 receptor antagonist actions

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1335

21 January 2018

The emerging role of glutamate in the pathophysiology and treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1335

21 January 2018

Amelioration of negative symptoms in schizophrenia by glycine.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1335

21 January 2018

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1335

21 January 2018

Striatal dopamine D2-receptor blockade by typical and atypical neuroleptics

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1335

21 January 2018

Clozapine, single photon emission tomography, and the D2 dopamine receptor blockade hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1335

21 January 2018

Clozapine-induced agranulocytosis. A genetic and epidemiologic study

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1335

21 January 2018

Active monitoring of 12,760 clozapine recipients in the UK and Ireland. Beyond pharmacovigilance.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1335

21 January 2018

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1335

21 January 2018

Clozapine: efficacy and safety

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1335

21 January 2018

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1335

21 January 2018

An open comparison of clozapine and risperidone in treatment-resistant schizophrenia

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1335

21 January 2018

Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1335

21 January 2018

Transient versus sustained visual channels in the visual backward masking deficits of schizophrenia patients

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1335

21 January 2018

Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1335

21 January 2018

Seroquel: biochemical profile of a potential atypical antipsychotic

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1335

21 January 2018

Ziprasidone: a new atypical antipsychotic

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1335

21 January 2018

Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1335

21 January 2018

Safety, tolerability, and effect of food on the pharmacokinetics of iloperidone (HP 873), a potential atypical antipsychotic

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1335

21 January 2018

The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1335

21 January 2018

Neurobehavioral Deficits at Adolescence in Children at Risk for Schizophrenia

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1335

21 January 2018

Dopamine D3 receptor gene polymorphism and response to clozapine in schizophrenic Pakistani patients

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1335

21 January 2018

Identifiers

10.1517/13543784.11.10.1335

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34974846&oldid=896609052"